Semler Scientific (SMLR) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/30/2026
- Wall St climbs as cooling inflation tempers Fed rate-hike concerns
- Equity positioning stays overweight, but summer extremes have eased: Barclays
- Oil gains as stalled US-Iran talks trump supply recovery
- Micron reports Q4 today: Why Lynx Equity sees massive upside
- Moderna: Citi says oncology optimism is priced in, cuts rating to sell
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- S&P 500 flat as higher bond yields counter tech optimism
- Mattel names Roger Lynch as chairman and CEO, replacing Ynon Kreiz
- HPE raises networking revenue outlook, secures $1.2B Vultr order
Semler Reports Second Quarter 2015 Financial Results
July 31, 2015 8:03 AM EDTPORTLAND, Ore., July 31, 2015 /PRNewswire/ --Â Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides diagnostic and testing services to healthcare insurers and physician groups, today reported financial results for the second quarter ended June 30, 2015.
"In the second quarter of 2015, Semler reported continued progress with year over year revenue growth of 54%, quarter over quarter revenue growth of 8%, and quarter over quarter growth of the installed base of FloChec® units of 18%," said Doug Murphy-Chutorian, M.D., chief executive officer of Semler. "During this period, we also expanded business with existing clients, made progress on... More
